Credits Available: 4.75 hours of AMA PRA Category 1 Credit™ with ABIM MOC

Description: This curriculum is designed to enhance knowledge, competence, and confidence among oncology clinicians regarding second-line therapy for small cell lung cancer (SCLC). Learners will explore evidence-based treatment sequencing, adverse event management, and emerging clinical trial data to optimize patient outcomes.

CME/CE Accreditation Information

If you already have a Gather-ed account, please login

Email:
Password:

Register

Step 1 of 3

This program is intended for:
Target Professions: DO, MD, Nurse, Nurse Practitioner, Physician Associate/Assistant
Target Specialties: Oncology, Hematology/Oncology

Melvin Rivera

MD Anderson Cancer Center
Clinical Pharmacy Specialist - Thoracic, Head and Neck Medical Oncology

Clinical Pharmacy Specialist in the area of Thoracic, Head and Neck Medical Oncology (THNMO) at MD Anderson Cancer center for the last 16 years. I have worked in both the inpatient and outpatient setting and work alongside medical oncologist and APP's to provide safe and effective oncologic care to THNMO patients. I graduated from Northeastern University Bouve College of Health Sciences in 2005 and completed a PGY-1 and PGY-2 (Oncology) residencies at Boston Medical Center in Boston, MA 2007.